AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
169.85
-2.25 (-1.31%)
Oct 9, 2025, 3:54 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $266.87 billion as of October 9, 2025. Its market cap has increased by 10.23% in one year.
Market Cap
266.87B
Enterprise Value
292.04B
Revenue
56.50B
Ranking
n/a
PE Ratio
32.17
Stock Price
$169.85
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 266.87B, an increase of 3,658.28%. That is a compound annual growth rate of 11.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 266.28B | 31.06% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | 131.26B | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 277.90M |
| Silence Therapeutics | 242.78M |